GoodRx Holdings, Inc. (GDRX)

Market Cap	675.47M -64.1%
Revenue (ttm)	796.85M +0.6%
Net Income	30.44M +85.7%
EPS	0.09 +113.6%
Shares Out	339.43M
PE Ratio	23.30
Forward PE	11.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,918,648
Open	1.990
Previous Close	2.450
Day's Range	1.920 - 2.080
52-Week Range	1.920 - 5.810
Beta	1.50
Analysts	Buy
Price Target	4.78 (+140.2%)
Earnings Date	Feb 25, 2026

About GDRX

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, ...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Sep 23, 2020
• Employees: 738
• Stock Exchange: NASDAQ
• Ticker Symbol: GDRX
• Website: https://www.goodrx.com

Financial Performance

In 2025, GoodRx Holdings's revenue was $796.85 million, an increase of 0.57% compared to the previous year's $792.32 million. Earnings were $30.44 million, an increase of 85.72%.

Analyst Summary

According to 10 analysts, the average rating for GDRX stock is "Buy." The 12-month stock price target is $4.78, which is an increase of 140.20% from the latest price.

Price Target

$4.78

(140.20% upside)

Analyst Consensus: Buy